Abstract: Various aspects and embodiments of the present invention are directed to methods of treating a subject having an ocular condition, methods of isolating ocular stem cells, methods of selecting and/or producing ocular grafts for transplantation, and methods of promoting ocular cell regeneration as well as to grafts and preparations containing isolated ocular stem cells characterized by the expression of ABCB5 on their cell surface.
Type:
Application
Filed:
October 30, 2017
Publication date:
March 8, 2018
Applicants:
VA Boston Healthcare System, Schepens Eye Research Institute, Children's Medical Center Corporation
Inventors:
Markus H. Frank, Natasha Y. Frank, Bruce Ksander, Paraskevi Evi Kolovou
Abstract: Various aspects and embodiments of the present invention are directed to methods of treating a subject having an ocular condition, methods of isolating ocular stem cells, methods of selecting and/or producing ocular grafts for transplantation, and methods of promoting ocular cell regeneration as well as to grafts and preparations containing isolated ocular stem cells characterized by the expression of ABCB5 on their cell surface.
Type:
Grant
Filed:
February 19, 2014
Date of Patent:
October 31, 2017
Assignees:
VA Boston Healthcare System, Schepens Eye Research Institute, Children's Medical Center Corporation
Inventors:
Markus H. Frank, Natasha Y. Frank, Bruce Ksander, Paraskevi Evi Kolovou
Abstract: The present invention is directed to wound healing scaffolds cografted with a population of stem cells, wherein the population of stem cells are ABCB5+ stem cells. The scaffolds are, for instance, collagen glycosaminoglycan scaffolds.
Type:
Application
Filed:
May 9, 2014
Publication date:
April 21, 2016
Applicants:
Va Boston Healthcare System, The Brigham and Women's Hospital, Inc., Children's Medical Center Corporation
Inventors:
Markus H. Frank, Natasha Y. Frank, Dennis P. Orgill, George F. Murphy
Abstract: Various aspects and embodiments of the present invention are directed to methods of treating a subject having an ocular condition, methods of isolating ocular stem cells, methods of selecting and/or producing ocular grafts for transplantation, and methods of promoting ocular cell regeneration as well as to grafts and preparations containing isolated ocular stem cells characterized by the expression of ABCB5 on their cell surface.
Type:
Application
Filed:
February 19, 2014
Publication date:
December 31, 2015
Applicants:
VA BOSTON HEALTHCARE SYSTEM, SCHEPENS EYE RESEARCH INSTITUTE, CHILDREN'S MEDICAL CENTER CORPORATION
Inventors:
Markus H. Frank, Natasha Y. Frank, Bruce Ksander